Epidemiological studies have shown that exposure to BPA could have negative effects on NAFLD-related biomarkers, with higher levels of urinary BPA correlating with increased ALT levels [73]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.